Cyramza Masterclass

Activity: Consultancy typesWork on advisory panel to industry or government or non-government organisation


Presentation of research and relevant to the development of the angiogenesis inhibitor Ramucirumab. I presented our work on angiogenesis biomarkers.
Period22 Jun 201523 Jun 2015
Work forEli Lilly & Company Ltd, United Kingdom
Degree of RecognitionNational